Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity

Clinica Chimica Acta

Volumn 380, Issue 1-2, 2007, Pages 151-156

  Boopathy, Rathanam ^a   Rajesh, Ramanna Valmiki ^a   Darvesh, Sultan ^b   Layer, Paul G ^c  

^a BHARATHIAR UNIVERSITY   (India)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aryl acylamidase; Butyrylcholinesterase; Gamma glutamyltransferase; Glutamate oxaloacetate transferase

Indexed keywords

ARYL ACYLAMIDASE; ASPARTATE AMINOTRANSFERASE; BOVINE SERUM ALBUMIN; CHOLINESTERASE; GAMMA GLUTAMYLTRANSFERASE; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER DISEASE; LIVER FUNCTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SERUM;

AMIDOHYDROLASES; ASPARTATE AMINOTRANSFERASES; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; ENZYME TESTS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER DISEASES; LIVER EXTRACTS; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY;

EID: 33947684265     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.02.001     Document Type: Article

References (35)

1. Brimijoin S., and Koenigsberger C. Cholinesterases in neural development: new findings and toxicologic implications. Environ Health Perspect 107 Suppl 1 (1999) 59-64
2. Souza R.L., Mikami L.R., Maegawa R.O., and Chautard-Freire-Maia E.A. Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. Mol Genet Metab 84 (2005) 349-353
3. Lockridge O. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47 (1990) 35-60
4. Layer P.G., and Willbold E. Novel functions of cholinesterases in development, physiology and disease. Prog Histochem Cytochem 29 (1995) 1-93
5. Ostergaard D., Viby-Mogensen J., Hanel H.K., and Skovgaard L.T. Half-life of plasma cholinesterase. Acta Anaesthesiol Scand 32 (1988) 266-269
6. Drews U. Cholinesterase in embryonic development. Prog Histochem Cytochem 7 (1975) 1-52
7. Soreq H., Lapidot-Lifson Y., and Zakut H. A role for cholinesterases in tumorigenesis?. Cancer Cells 3 (1991) 511-516
8. Grisaru D., Sternfeld M., Eldor A., Glick D., and Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 264 (1999) 672-686
9. Layer P.G., Weikert T., and Alber R. Cholinesterases regulate neurite growth in chick nerve cells invitro by means of a nonenzymatic mechanism. Cell Tissue Res 273 (1993) 219-226
10. Li B., Stribley J.A., Ticu A., et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75 (2000) 1320-1331
11. Xie W., Stribley J.A., Chatonnet A., et al. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 293 (2000) 896-902
12. Duysen E.G., Bartels C.F., and Lockridge O. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells 16-hour half-life in the circulation and protect mice from cocaine toxicity. J Pharmacol Exp Ther 302 (2002) 751-758
13. Sun H., Shen M.L., Pang Y.P., Lockridge O., and Brimijoin S. Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. J Pharmacol 302 (2002) 710-716
14. Balasubramanian A.S., and Bhanumathy C.D. Noncholinergic functions of cholinesterases. FASEB J 7 (1993) 1354-1358
15. Checler F., Grassi J., and Vincent J.P. Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J Neurochem 62 (1994) 756-763
16. Weitnauer E., Robitzki A., and Layer P.G. Aryl acylamidase activity exhibited by butyrylcholinesterase is higher in chick than in horse, but much lower than in fetal calf serum. Neurosci Lett 254 (1998) 153-156
17. Boopathy R., and Layer P.G. Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Protein J 23 (2004) 325-333
18. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemistry 7 (1961) 88-95
19. Marc V., Victor G., and Massoulie J. Nonspecific cholinesterase and acetylcholinesterase in rat tissues: molecular forms, structural and catalytic properties, and significance of the two enzyme systems. Proc Natl Acad Sci 75 (1978) 2588-2592
20. George S.T., and Balasubramanian A.S. The identity of the serotonin-sensitive aryl acylamidase with acetylcholinesterase from in human erythrocytes, and sheep basal ganglion and electric eel. Eur J Biochem 111 (1980) 511-524
21. Kumar V., Giacobini E., and Markwell S. CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patients. Acta Anaesthesiol Scand 80 (1989) 461-466
22. Lowry O.H., Rosebrough N.J., and Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem 193 (1951) 265-269
23. Zweigand M.H., and Campbell G. Receiver-Operating Characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
24. George S.T., and Balasubramanian A.S. The aryl acylamidase and their relationship to cholinesterase in human serum, erythrocyte and liver. Eur J Biochem 121 (1981) 177-186
25. Tsim K.W., Randall W.R., and Barnard E.A. Monoclonal antibodies specific for the different subunits of asymmetric acetylcholinesterase from chick muscle. J Neurochem 51 (1988) 95-104
26. Ogunkeye O.O., and Roluga A.I. Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver functional tests. Pathophysiology 13 (2006) 91-93
27. Koenigsberger C., Hammond P., and Brimijoin S. Developmental expression of acetyl-and butyrylcholinesterase in the rat: enzyme and mRNA levels in embryonic dorsal root ganglia. Brain Res 787 (1998) 248-258
28. Robitzki A., Mack A., Chatonnet A., and und Layer P.G. Transfection of reaggregating embryonic chicken retinal cells with an antisense-5′DNA butyryl-cholinesterase expression vector inhibits proliferation and alters morphogenesis. J Neurochem 69 (1997) 823-833
29. Robitzki A., Doll F., Richter-Landsberg C., and Layer P.G. Regulation of the rat oligodendroglia cell line OLN-93 by antisense transfection of butyrylcholinesterase. Glia 31 (2000) 195-205
30. Wright C.I., Geula C., and Mesulam M.M. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Ann Neurol 34 (1993) 373-384
31. Lehmann D.J., Nagy Z., Litchfield S., Borja M.C., and Smith A.D. Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease. Hum Genet 106 (2000) 447-452
32. Darvesh S., MacKnight C., and Rockwood K. Butyrylcholinesterase and cognitive function. Int Psychogeriatr 13 (2001) 461-464
33. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 4 (2003) 31-138
34. Layer P.G. Cholinesterases preceding major tracts in vertebrate neurogenesis. Bioessays 12 (1990) 415-420
35. Nalivaeva N.N., and Turner A.J. Post-translational modification of proteins: acetylcholinesterase as a model system. Proteomics 1 (2001) 735-747